These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

508 related items for PubMed ID: 25700171

  • 1. Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology.
    Devalla HD, Schwach V, Ford JW, Milnes JT, El-Haou S, Jackson C, Gkatzis K, Elliott DA, Chuva de Sousa Lopes SM, Mummery CL, Verkerk AO, Passier R.
    EMBO Mol Med; 2015 Apr; 7(4):394-410. PubMed ID: 25700171
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Generation of a constitutive Na+-dependent inward-rectifier current in rat adult atrial myocytes by overexpression of Kir3.4.
    Mintert E, Bösche LI, Rinne A, Timpert M, Kienitz MC, Pott L, Bender K.
    J Physiol; 2007 Nov 15; 585(Pt 1):3-13. PubMed ID: 17884923
    [Abstract] [Full Text] [Related]

  • 7. Ultrarapid Delayed Rectifier K+ Channelopathies in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Hilderink S, Devalla HD, Bosch L, Wilders R, Verkerk AO.
    Front Cell Dev Biol; 2020 Nov 15; 8():536. PubMed ID: 32850774
    [Abstract] [Full Text] [Related]

  • 8. Chamber-specific contractile responses of atrial and ventricular hiPSC-cardiomyocytes to GPCR and ion channel targeting compounds: A microphysiological system for cardiac drug development.
    Lickiss B, Hunker J, Bhagwan J, Linder P, Thomas U, Lotay H, Broadbent S, Dragicevic E, Stoelzle-Feix S, Turner J, Gossmann M.
    J Pharmacol Toxicol Methods; 2024 Nov 15; 128():107529. PubMed ID: 38857637
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of Batch Variations in Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes from 2 Major Suppliers.
    Huo J, Kamalakar A, Yang X, Word B, Stockbridge N, Lyn-Cook B, Pang L.
    Toxicol Sci; 2017 Mar 01; 156(1):25-38. PubMed ID: 28031415
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Theoretical possibilities for the development of novel antiarrhythmic drugs.
    Varró A, Biliczki P, Iost N, Virág L, Hála O, Kovács P, Mátyus P, Papp JG.
    Curr Med Chem; 2004 Jan 01; 11(1):1-11. PubMed ID: 14754422
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Modeling Atrial Fibrillation using Human Embryonic Stem Cell-Derived Atrial Tissue.
    Laksman Z, Wauchop M, Lin E, Protze S, Lee J, Yang W, Izaddoustdar F, Shafaattalab S, Gepstein L, Tibbits GF, Keller G, Backx PH.
    Sci Rep; 2017 Jul 13; 7(1):5268. PubMed ID: 28706272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.